Rhodex-Puguet has long been a leader in the specialty chemicals market. Its success has been attributed to heavy investment in R&D, but lately, instead of producing innovative, new products, it’s having problems with missed deadlines, overworked staff and unclear expectations. So what does a firm do when it finds its R&D suddenly stands for Returns Declining? Professor Arnoud De Meyer challenges you to find the … [ Read more ]
Content: Case Study | Author: Arnoud De Meyer | Source: INSEAD | Subjects: Industry Specific, Strategy | Industry: Pharmaceutical | Company: Rhodex-Puguet S.A.